Cytrellis provides the ellacor® system, an FDA‑cleared medical device that uses Micro‑Coring® Technology to remove microscopic columns of dermal tissue for precise skin tightening with minimal downtime. The platform features automated depth control, single‑use cartridges, and HIPAA‑compliant cloud logging, enabling dermatologists, plastic surgeons, and medspa physicians to integrate non‑surgical rejuvenation into existing practice workflows.
Funding
Funding not disclosed
Founders
Product
Problem
Age-related skin laxity and sagging present a persistent aesthetic concern, yet many existing treatments either require extensive surgical intervention or provide limited precision, leading to longer recovery times and variable outcomes.
Solution
Cytrellis offers the ellacor® system, a medical device that employs FDA‑cleared Micro‑Coring® Technology to excise microscopic columns of dermal tissue, thereby tightening skin without full‑thickness excision. The device delivers controlled, sub‑millimeter coring that preserves surrounding vasculature, reducing inflammation and downtime compared with conventional resurfacing or surgical lifts. Integrated cartridge loading and automated depth control enable practitioners to target specific treatment zones with repeatable results. Data from each procedure are logged to a secure cloud portal, allowing clinicians to track patient progress and adjust protocols over time. The system is compatible with standard aesthetic practice infrastructure and can be incorporated into existing treatment workflows with minimal training.
Target Audience
The primary customers are board‑certified dermatologists, plastic surgeons, and medspa physicians who deliver non‑surgical facial rejuvenation and body contouring services.
Features
- FDA‑cleared Micro‑Coring® Technology that removes skin tissue at a 0.5 mm to 1.0 mm scale for precise tightening
- Single‑use, pre‑loaded coring cartridges that ensure sterility and consistent performance across cases
- Automated depth and coring density settings with real‑time impedance feedback to maintain target tissue removal
- Minimal epidermal disruption, resulting in reduced erythema, edema, and patient downtime (typically ≤ 48 hours)
- Integrated procedural logging to a HIPAA‑compliant cloud dashboard for outcome tracking and analytics
- Compatibility with standard aesthetic clinic equipment (power supply, suction, and lighting) and a compact footprint for easy room placement
- Training module and certification program that can be completed in a single day of hands‑on practice